|
|
Thomson Financial Business Description:
| The Company's principal activity is to discover and develop pharmaceutical products for the treatment of human cancers. The product developed by the Company may represent a novel treatment for Ras mediated cancers which can be used as an alternative to existing cytotoxic or cytostatic therapies as an adjuvant therapy to conventional chemotherapy, radiation therapy or surgical resections or to treat certain cellular proliferative disorders for which no current therapy exists. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Oncolytics Biotech Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
